Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005058234 | SCV005697705 | pathogenic | not provided | 2024-11-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr415Ilefs*12) in the EIF2AK4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EIF2AK4 are known to be pathogenic (PMID: 12215525, 24135949, 24292273, 24310610, 28972005, 29743074). This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with EIF2AK4-related conditions. ClinVar contains an entry for this variant (Variation ID: 1706636). For these reasons, this variant has been classified as Pathogenic. |
John Welsh Cardiovascular Diagnostic Laboratory, |
RCV002285245 | SCV002575059 | pathogenic | Pulmonary arterial hypertension | 2022-09-26 | no assertion criteria provided | clinical testing |